Skip to search formSkip to main contentSkip to account menu

Factor VIIa

Known as: VIIa, Coagulation Factor, Coagulation factor VIIa, Factor VIIa [Chemical/Ingredient] 
Activated form of factor VII. Factor VIIa activates factor X in the extrinsic pathway of blood coagulation.
National Institutes of Health

Related topics

Related topics

17 relations
CoagulantsProcess of secretionagonistsantagonists & inhibitors

Narrower (7)

MC710Novosevendes(1-38) factor VIIaglycoPEGylated factor VIIa

Broader (1)

factor VII

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition
In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition - 
2008
2008
[Our experince with the use of recombinant activated factor VII in postpartum haemorrhage].
INTRODUCTION Massive obstetric bleeding is the most common cause of maternal mortality and morbidity. The first step in treatment… 
Review
2007
Review
2007
The use of recombinant activated factor VII in life‐threatening postpartum hemorrhage
SUMMARY Bleeding is still a major cause of morbidity and mortality in obstetrics. As recent reports have documented the… 
2007
2007
A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation
Recombinant activated factor VII (NovoSeven, rFVIIa) is used to abrogate bleeding in haemophiliacs with inhibitors and is… 
2001
2001
Experiences with Recombinant Factor VIIa for the Prevention of Bleeding in Patients with Chronic Liver Disease Undergoing Percutaneous Liver Biopsies and Endoscopic Retrograde…
Experiences with Recombinant Factor VIIa for the Prevention of Bleeding in Patients with Chronic Liver Disease Undergoing… 
Review
2000
Review
2000
The Regulation of the Factor VII-Dependent Coagulation Pathway: Rationale for the Effectiveness of Recombinant Factor VIIa in Refractory Bleeding Disorders
We have explored the molecular basis of the clinical therapeutic effect of factor VIIa in hemophilia A using empirical… 
2000
2000
Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns
Factor (F) VIIa has been used to treat adults and children with a variety of bleeding disorders. The results from these studies… 
1999
1999
Successful treatment of acquired factor VIII inhibitor with fludarabine and cyclophosphamide in chronic lymphoid leukemia
Successful treatment of acquired factor VIII inhibitor with fludarabine and cyclophosphamide in chronic lymphoid leukemia 
Review
1995
Review
1995
Tissue factor: regulation of activity by flow and phospholipid surfaces.
Tissue factor (TF), a transmembrane protein, is the main initiator of blood clotting in vivo which functions by complexing the… 
1994
1994
Identification of the factor VIIa binding site on tissue factor by homologous loop swap and alanine scanning mutagenesis.
Tissue factor (TF) is a membrane-bound glycoprotein that functions as a cofactor for coagulation factor VIIa (VIIa) and initiates…